Highlights CG Invites Co., Ltd.

Equities

A083790

KR7083790006

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-06-06 pm EDT			5-day change	1st Jan Change
2,515 ^KRW	+0.60%		+3.29%	-9.37%

May. 14	CG Invites Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 18	Hwail Pharmaceutical Co.,Ltd. announced that it has received KRW 19.0999977 billion in funding from Osung Advanced Materials Co., Ltd., Kumho HT, Inc., CrystalGenomics Invites Co., LTD.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CG Invites Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 14	CI
CG Invites Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 15	CI
An unknown buyer cancelled the acquisition of 2.40% stake in CrystalGenomics, Inc. from Kumho HT, Inc.	Dec. 13	CI
CrystalGenomics Invites Co., LTD. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
CrystalGenomics Invites Co., LTD. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-17	CI
CrystalGenomics Invites Co., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
An unknown buyer agreed to acquire approximately 2.40% stake in CrystalGenomics, Inc. from Kumho HT, Inc for KRW 28 billion.	23-03-29	CI
CrystalGenomics, Inc. agreed to acquire 20.43% stake in PanGen Biotech Inc. from the group of shareholders for approximately KRW24 billion.	22-11-21	CI
CrystalGenomics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
CrystalGenomics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-16	CI
CrystalGenomics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Tranche Update on CrystalGenomics, Inc.'s Equity Buyback Plan announced on February 15, 2022.	22-05-16	CI
Tranche Update on CrystalGenomics, Inc.'s Equity Buyback Plan announced on February 15, 2022.	22-05-16	CI
CrystalGenomics, Inc.'s Equity Buyback announced on February 15, 2022, has expired with 688,603 shares, representing 1.01% for KRW 4,503.53 million.	22-05-15	CI
CrystalGenomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-18	CI
Tranche Update on CrystalGenomics, Inc.'s Equity Buyback Plan announced on February 15, 2022.	22-02-15	CI
CrystalGenomics, Inc. announces an Equity Buyback for KRW 5,000 million worth of its shares.	22-02-15	CI
CrystalGenomics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
CrystalGenomics, Inc. authorizes a Buyback Plan.	21-11-14	CI
Tranche Update on CrystalGenomics, Inc.'s Equity Buyback Plan announced on April 5, 2021.	21-10-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights CG Invites Co., Ltd.

Equities

A083790

KR7083790006

Highlights

Filters